References
- Colman SS, Brod M, Potter LP, et al. Cross-sectional 7-year follow-up of anxiety in primary care patients. Depress. Anxiety 2004;19:105–11
- Nathan DM, Buse JB, Davidson MB, et al.; American Diabetes Association; European Association for Study of Diabetes. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009;32:193-203
- The 3rd International DAWN Summit: from research and practice. Pract Diabetes Int 2006;23:313–16
- Hirose T. Biphasic insulin analogue -- profiles and clinical application in comparison with other pre-mixed insulin. [Shinryō] Diagnosis and Treatment, 2006;94:2349-53
- Kawamori R, Kasuga M, Kadowaki T, et al. Safety and efficacy of biphasic insulin aspart 30 in Japanese type-2 diabetes - IMPROVE Study JAPAN. Jpn Pharmacol Ther 2009;37:233-41
- Iwamoto Y, Atsumi Y, Awata T, et al. Questionnaire Concerning Physician Resource Utilization of Biphasic Insulin Aspart 30 (BIAsp 30) in patients with type 2 Diabetes (T2D) -- IMPROVE study in Japan. Jpn J Diabet Mast Clin 2009; submitted for publication
- Good Postmarketing Study Practice (GPSP). Ministry of Health, Labour and Welfare [MHLW] Ministerial Ordinance No.171. Dec 2004
- Good Vigilance Practice (GVP). Ministry of Health, Labour and Welfare [MHLW] Ministerial Ordinance No.135. Sep 2004
- Brod M, Skovlund SE, Wittrup-Jensen KU. Measuring the impact of diabetes through patient report of treatment satisfaction, productivity and symptom experience. Qual Life Res 2006;15:481-91
- Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation health related quality of life measures: Literature review and proposed guidelines. J. Clin Epidemiol 1993;46:1417-32
- Ikegami N, Fukuhara S, Shimotsuma A, et al. Clinical Handbook for QOL Evaluation. Tokyo, Igakushoin, 2001:8-13
- Ishii H, Shuto Y, Okuyama S. Development of the Japanese Version of the Diabetes Medication Satisfaction Questionnaire(Diab-MedSat). J Jpn Diabetes Soc 2009;52:527-35
- Brod M, Kongsø JH, Lessard S, et al. Psychological insulin resistance: patient beliefs and implications for diabetes management. Qual Life Res 2009;18:23-32
- Nakar S, Yitzhaki G, Rosenberg R, et al. Transition to insulin in type 2 diabetes: family physicians' misconception of patients' fears contributes to existing barriers. J Diabetes Complications 2007;21:220-6
- The DCCT Research Group (1991) Epidemiology of severe hypoglycemia in the diabetes control and complications trials. Am J Med 1991;90:450–9
- Ishii H, Furuya M, Iburi T, et al. Insulin therapy related QOL at night (ITR-QOLN). J Jpn Diabetes Soc 2008;51:601-8
- Ishii H, Yamamoto Y, Ohashi Y. Quality of life in insulin users measured by ITR-QOL. J Jpn Diabetes Soc 2001;44:17-22
- Yamada S, Tamada T, Watanabe M, et al. Comparison of biphasic insulin aspart 30/70 and premixed human insulin 30/70: glycemic control and quality-of-life in insulin-naïve type 2 diabetic patients. Clin Pract 2007;26:58-64
- Kobayashi T, Yamazaki K, Kanetsuka A. Japan Diabetes Clinical Data Management Study Group (2006) CoDiC(R): Surveillance of clinical management of diabetes in Japan (2nd report). Jpn J Diabetes Mast Clin 2006;4:751-5
- Odawara M, Saito Y, Hayashi Y, et al. DAWN Japan Study Group. DAWN Japan study 1–5. J Jpn Diabetes Soc 2006;49(Suppl):S187